Kliniska studier för Migrän i Georgia
9 studier för Migrän söker deltagare vid platser i Georgia.
Städer i Georgia
Officiell studietext (engelska)
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
RekryterarFas 1
Ålder 6 till 11 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Rekryterar
Ålder 10 till 17 · Alla kön · Uppdaterad 21 sep. 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- och 1 fler
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Rekryterar
Ålder 22 till 84 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07645924Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.